Source: iQoncept / Shutterstock
ENDRA Life Sciences (NASDAQ:NDRA) has once again astounded the market with their Q4 2023 earnings report.
- Despite the challenges, ENDRA Life Sciences reported a remarkable earnings per share of -5 cents, surpassing the projected EPS of -36 cents by a significant margin.
- Although the company did not disclose any revenue figures for the quarter, their EPS performance alone has left investors buzzing with excitement.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/ndra-stock-earnings-endra-life-sciences-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
